A detailed history of Penobscot Investment Management Company, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penobscot Investment Management Company, Inc. holds 15,128 shares of BMY stock, worth $873,793. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,128
Previous 15,204 0.5%
Holding current value
$873,793
Previous $631,000 23.93%
% of portfolio
0.07%
Previous 0.06%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$39.66 - $51.75 $3,014 - $3,933
-76 Reduced 0.5%
15,128 $782,000
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $52,083 - $68,569
-1,294 Reduced 7.84%
15,204 $631,000
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $93,033 - $105,481
-1,939 Reduced 10.52%
16,498 $894,000
Q4 2023

Feb 05, 2024

BUY
$48.48 - $57.85 $29,087 - $34,710
600 Added 3.36%
18,437 $946,000
Q3 2023

Nov 08, 2023

BUY
$57.89 - $64.73 $404,766 - $452,592
6,992 Added 64.47%
17,837 $1.04 Million
Q2 2022

Aug 11, 2022

SELL
$72.62 - $79.98 $164,121 - $180,754
-2,260 Reduced 17.25%
10,845 $836,000
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $126,034 - $151,126
2,050 Added 18.54%
13,105 $957,000
Q3 2021

Nov 08, 2021

SELL
$59.17 - $69.31 $4,615 - $5,406
-78 Reduced 0.7%
11,055 $655,000
Q2 2021

Aug 09, 2021

SELL
$61.91 - $67.42 $247,640 - $269,680
-4,000 Reduced 26.43%
11,133 $744,000
Q1 2021

May 07, 2021

SELL
$59.34 - $66.74 $5,340 - $6,006
-90 Reduced 0.59%
15,133 $955,000
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $44,623 - $49,448
-777 Reduced 4.86%
15,223 $918,000
Q1 2020

May 07, 2020

BUY
$46.4 - $67.43 $38,512 - $55,966
830 Added 5.47%
16,000 $892,000
Q4 2019

Feb 04, 2020

BUY
$49.21 - $64.19 $25,589 - $33,378
520 Added 3.55%
15,170 $973,000
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $3,609 - $4,304
-80 Reduced 0.54%
14,650 $699,000
Q4 2018

Feb 12, 2019

SELL
$48.76 - $63.23 $48,760 - $63,230
-1,000 Reduced 6.36%
14,730 $766,000
Q1 2018

May 07, 2018

BUY
$59.92 - $68.98 $232,190 - $267,297
3,875 Added 32.69%
15,730 $995,000
Q4 2017

Feb 05, 2018

SELL
$59.94 - $65.35 $11,988 - $13,069
-200 Reduced 1.66%
11,855 $726,000
Q3 2017

Nov 02, 2017

BUY
$55.23 - $63.74 $665,797 - $768,385
12,055
12,055 $768,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Penobscot Investment Management Company, Inc. Portfolio

Follow Penobscot Investment Management Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penobscot Investment Management Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Penobscot Investment Management Company, Inc. with notifications on news.